PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC6628374::ACT050285

E9

Evidence text

Paper-level observation

Table 5: E9 Trp-Leu IC50 26.80 ± 0.90 μM (0.00851 mg/mL).
tableConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
ACE Inhibitor
Measure
other
Comparator
=
Raw observation
26.80 ± 0.90 µM
Normalized measurement
=26.8 µM
Value minimum
25.9 µM
Value maximum
27.7 µM
Target
Angiotensin I-converting enzyme (ACE)
Assay method
Not reported by source
Sequence
WL
Standardization
ready simple

Source publication

Preparation and Identification of Novel Antihypertensive Peptides from the In Vitro Gastrointestinal Digestion of Marine Cobia Skin Hydrolysates.

Nutrients · 2019

DOI 10.3390/nu11061351 PMC6628374
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-004157PEPDIA-INT-001004

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.